Itau Unibanco Holding S.A.’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-335	Closed	-$1.02K	–	728
2019 Q2	$2K	Buy	335 +26	+8%	+$146	﹤0.01%	622
2019 Q1	$1K	Hold	309	–	–	﹤0.01%	587
2018 Q4	$1K	Buy	309 +58	+23%	+$406	﹤0.01%	587
2018 Q3	$2K	Sell	251 -19	-7%	-$211	﹤0.01%	587
2018 Q2	$3K	Buy	+270	New	+$3.7K	﹤0.01%	740

Other funds holding NTGN

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HMC

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Itau Unibanco Holding S.A.'s NTGN Position: Q3 2019 in Review

Itau Unibanco Holding S.A. sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q3 2019, closing a stake of 335 shares — an estimated $1.02K sold.

Itau Unibanco Holding S.A. first reported a position in NTGN in Q2 2018 and held it in 5 quarters. The position peaked at $3K in Q2 2018. 58 funds tracked by Wall St. Rank hold NTGN as of Q3 2019.

Itau Unibanco Holding S.A. reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 335 Neon Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $1.02K.
Itau Unibanco Holding S.A. first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
Itau Unibanco Holding S.A.'s Neon Therapeutics, Inc. Common Stock position peaked at $3K in Q2 2018.
58 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2019, filed 14 Nov 2019.